检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:胡奇志[1] 方万强[1] 吴瑞景[1] 黄旭毅[1]
出 处:《四川肿瘤防治》2006年第3期190-192,共3页Sichuan Journal of Cancer Control
摘 要:目的:评价复方丹参滴丸联合NP方案治疗中晚期乳腺癌的疗效、免疫功能、生存质量和毒副反应。方法:100例中晚期乳腺癌患者随机分为联合组、单纯化疗组,联合组(51例)采用复方丹参滴丸加NP方案治疗,单纯化疗组(49例)采用单纯NP方案化疗,进行近期疗效、免疫功能、生存质量和毒副反应的随机对照研究。结果:联合组、单纯化疗组的有效率分别为56.9%和46.9%(P>0.05),临床获益率分别为92.2%和73.5%(P<0.05),联合组治疗后T淋巴细胞亚群中的CD4/CD8比值有明显提高(P<0.01),而单纯化疗组治疗后T淋巴细胞亚群中的CD4/CD8比值有明显减低(P<0.01),生存质量联合组高于单纯化疗组(P<0.05),恶心呕吐、感觉神经毒性、白细胞减少及粘膜炎单纯化疗组高于联合组(P<0.05)。结论:复方丹参滴丸联合化疗治疗乳腺癌能提高患者的治疗临床获益率、增强乳腺癌患者的细胞免疫功能,提高生存质量、减轻化疗某些不良反应。Objective: To observe the therapeutic effect, the cell immunology, quality of life and toxicity in advanced breast carcinoma treated with composite salviae dropping pill in combination with NP regimen chemotherapy. Methods: 100 patients with advancod breast carcinoma were randomly divided to receive NP regimen combined with composite salviae dropping pill( combined group, 51 cases) or NP regimen only(chemotherapy alone group, 49 cases). Results: The objective response rate( Complete remission + Partial ression, CR + PR) was 56. 9% in combined group, compared to 46. 9% in chemotherapy alone group ( P 〉 0. 05), the clinical benefit response rate( Complete Remission + Partial Bession + Stable Disease, CR + PR + SD) was 92. 2% in combined group, compared to 73. 5% in group of chemotherapy (P 〈 0. 05), the level of CD4/CD8 was significantly increased in combined group (P 〈 0. 01 ), the level of CD4/ CD8 was significantly decreased in group of chemotherapy along(P 〈0.01), quality of life in combined group was higher than that in group of chemotherapy along(P 〈0. 05). Nausea, vomiting, sensory neurotoxicity, leukopenia, and mucitis in group of chemotherapy alon were more serious than in combined group (P 〈 0. 05). Conclusion: Composite salviae dropping pill can give a satisfactory clinical henefit response rate, decrease side effects of chemotherapy, improve quality of life in the patients with breast carcinoma and enhance the immunofunetious of the patients with breast carcinoma treated with chemotherapy.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3